Search results - 10 results

Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.

Antibodies, Viral BNT162 Vaccine Breakthrough Infections COVID-19 COVID-19 Vaccines Humans Immunity nursing homes Population Groups RNA, Messenger SARS-CoV-2 Abstract: BACKGROUND: Nursing home residents, ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)

vaccinated having received the last dose (eventually a booster) longer than 3 months ago, these percentages were respectively 93.8% and 95.7% Among people who had not received any COVID-19 vaccine at all the ...

Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study

Among the unvaccinated, having a non-O blood type (OR a 2.00 (95% CI 1.09–3.67)) and having one or more positive COVID-19 tests (OR a 11.04 (95% CI 4.69–26.02)) were significantly associated. This study ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study

p.80 (2021) Accession Number: D/2021/14.440/86 Keywords: antibodies COVID-19 health determinants population-based Seroprevalence Abstract: Key findings In the beginning of July 2021 78.1% of the ...

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.

detected the first SARS-CoV-2-positive sample concomitantly with the first confirmed COVID-19 case with no travel history to China. Interpretation: The main burden of severe seasonal hCoV infection lies with ...

Consultations Corona: Participation citoyenne à la politique Belge de vaccination

COVID-19 participation citoyenne Vaccination Abstract: Le but des consultations corona était de faire en sorte que différents groupes de citoyens belges puissent délibérer d’une manière informée sur les ...

Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants

COVID-19 diagnosis is the detection of viral RNA by RT-qPCR with a specific set of primers and probe. It is important to frequently evaluate the performance of these tests and this can be done first by an in ...

Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection.

started in December 2019. COVID-19 cases are confirmed by the detection of SARS-CoV-2 RNA in biological samples by RT-qPCR. However, limited numbers of SARS-CoV-2 genomes were available when the first ...

Towards a European strategy to address the COVID-19 pandemic.

Barbara Prainsack; Joacim Rocklöv; Eva Schernhammer; Ewa Szczurek; Tsiodras, Sotirios; Steven Van Gucht; Peter Willeit Source: Lancet, Volume 398, Issue 10303 (2021) Keywords: COVID-19 COVID-19 Vaccines ...

Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2.

COVID-19 Humans SARS-CoV-2 Sensitivity and Specificity Seroepidemiologic Studies Serologic Tests Abstract: OBJECTIVES: Assess the performance of five SARS-CoV-2 rapid serological tests (RST) using finger ...

QR code

QR code for this page URL